- GMDAQ Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Gamida Cell (GMDAQ) Financial statements
Company Profile
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Cost of Revenue | |||||||
Gross Profit | |||||||
Gross Profit Margin (%) | |||||||
R&D Expense | |||||||
SG&A Expense | |||||||
Total Operating Expenses | |||||||
Operating Income or Loss | |||||||
Operating Margin (%) | |||||||
Interest Expense | |||||||
Total Other Income/Expenses | |||||||
Income Before Tax | |||||||
Income Tax Expense | |||||||
Income from Continuing Ops. | |||||||
Net Income | |||||||
Net Profit Margin (%) | |||||||
Net Income Available to Common Shareholders | |||||||
Basic EPS | |||||||
Diluted EPS | |||||||
Basic Average Shares | |||||||
Diluted Average Shares |
Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||
Cost of Revenue | ||||||||||||||
Gross Profit | ||||||||||||||
Gross Profit Margin (%) | ||||||||||||||
R&D Expense | ||||||||||||||
SG&A Expense | ||||||||||||||
Total Operating Expenses | ||||||||||||||
Operating Income or Loss | ||||||||||||||
Operating Margin (%) | ||||||||||||||
Interest Expense | ||||||||||||||
Total Other Income/Expenses | ||||||||||||||
Income Before Tax | ||||||||||||||
Income Tax Expense | ||||||||||||||
Income from Continuing Ops. | ||||||||||||||
Net Income | ||||||||||||||
Net Profit Margin (%) | ||||||||||||||
Net Income Available to Common Shareholders | ||||||||||||||
Basic EPS | ||||||||||||||
Diluted EPS | ||||||||||||||
Basic Average Shares | ||||||||||||||
Diluted Average Shares |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | ||
---|---|---|---|---|---|---|---|
Current Assets | |||||||
Cash & Cash Equivalents | |||||||
Marketable Securities | |||||||
Receivables | |||||||
Inventories | |||||||
Other Current Assets | |||||||
Total Current Assets | |||||||
Non-Current Assets | |||||||
Marketable Securities | |||||||
PPE Net | |||||||
Intangibles inc. Goodwill | |||||||
Other Non-Current Assets | |||||||
Total Non-Current Assets | |||||||
Total Assets | |||||||
Current Liabilities | |||||||
Accounts Payable | |||||||
Deferred Revenues | |||||||
Debt, Current | |||||||
Accrued Liabilities | |||||||
Other Current Liabilities | |||||||
Total Current Liabilities | |||||||
Non-Current Liabilities | |||||||
Deferred Revenues | |||||||
Debt, Non-Current | |||||||
Other Non-Current Liabilities | |||||||
Total Non-Current Liabilities | |||||||
Total Liabilities | |||||||
Shareholders' Equity | |||||||
Common Stock | |||||||
Additional Paid-In Capital | |||||||
Retained Earnings | |||||||
Other Shareholders' Equity | |||||||
Total Shareholders' Equity | |||||||
Total Liabilities & Shareholders' Equity |
Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||
Cash & Cash Equivalents | ||||||||||||||
Marketable Securities | ||||||||||||||
Receivables | ||||||||||||||
Inventories | ||||||||||||||
Other Current Assets | ||||||||||||||
Total Current Assets | ||||||||||||||
Non-Current Assets | ||||||||||||||
Marketable Securities | ||||||||||||||
PPE Net | ||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||
Other Non-Current Assets | ||||||||||||||
Total Non-Current Assets | ||||||||||||||
Total Assets | ||||||||||||||
Current Liabilities | ||||||||||||||
Accounts Payable | ||||||||||||||
Deferred Revenues | ||||||||||||||
Debt, Current | ||||||||||||||
Accrued Liabilities | ||||||||||||||
Other Current Liabilities | ||||||||||||||
Total Current Liabilities | ||||||||||||||
Non-Current Liabilities | ||||||||||||||
Deferred Revenues | ||||||||||||||
Debt, Non-Current | ||||||||||||||
Other Non-Current Liabilities | ||||||||||||||
Total Non-Current Liabilities | ||||||||||||||
Total Liabilities | ||||||||||||||
Shareholders' Equity | ||||||||||||||
Common Stock | ||||||||||||||
Additional Paid-In Capital | ||||||||||||||
Retained Earnings | ||||||||||||||
Other Shareholders' Equity | ||||||||||||||
Total Shareholders' Equity | ||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | ||
---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||
Net Income | |||||||
Depreciation & Amortization | |||||||
Deferred Income Taxes | |||||||
Stock Based Compensation | |||||||
Accounts Receivable | |||||||
Inventory | |||||||
Accounts Payable | |||||||
Deferred Revenue | |||||||
Other Non-Cash | |||||||
Operating Cash Flow | |||||||
Cash Flows from Investing Activities | |||||||
PPE Investments | |||||||
Net Acquisitions | |||||||
Purchase of Investments | |||||||
Sale of Investments | |||||||
Other Investing Activity | |||||||
Investing Cash Flow | |||||||
Cash Flows from Financing Activities | |||||||
Debt Issued | |||||||
Proceeds from Debt Repayment | |||||||
Debt Repayment | |||||||
Proceeds from Sale of Equity | |||||||
Equity Repurchased | |||||||
Dividend Paid | |||||||
Other Financing Activity | |||||||
Financing Cash Flow | |||||||
Cash Position | |||||||
Beginning Cash Position | |||||||
End Cash Position | |||||||
Change in Cash | |||||||
Free Cash Flow | |||||||
Operating Cash Flow | |||||||
Capital Expenditure | |||||||
Free Cash Flow |
Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||
Net Income | ||||||||||||||
Depreciation & Amortization | ||||||||||||||
Deferred Income Taxes | ||||||||||||||
Stock Based Compensation | ||||||||||||||
Accounts Receivable | ||||||||||||||
Inventory | ||||||||||||||
Accounts Payable | ||||||||||||||
Deferred Revenue | ||||||||||||||
Other Non-Cash | ||||||||||||||
Operating Cash Flow | ||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||
PPE Investments | ||||||||||||||
Net Acquisitions | ||||||||||||||
Purchase of Investments | ||||||||||||||
Sale of Investments | ||||||||||||||
Other Investing Activity | ||||||||||||||
Investing Cash Flow | ||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||
Debt Issued | ||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||
Debt Repayment | ||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||
Equity Repurchased | ||||||||||||||
Dividend Paid | ||||||||||||||
Other Financing Activity | ||||||||||||||
Financing Cash Flow | ||||||||||||||
Cash Position | ||||||||||||||
Beginning Cash Position | ||||||||||||||
End Cash Position | ||||||||||||||
Change in Cash | ||||||||||||||
Free Cash Flow | ||||||||||||||
Operating Cash Flow | ||||||||||||||
Capital Expenditure | ||||||||||||||
Free Cash Flow |